Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04378933 · ClinicalTrials.gov registry record · NA
Glasses for Adolescent Delayed Sleep-Wake Phase Disorder
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT04378933: Completed NA study, sponsored by Mayo Clinic.
NCT04378933 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04378933, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if evening amber glasses combined with stable wake times will show an increase in total sleep time (TST) and an advance in sleep onset times (shift earlier) compared to the control group.
Interventions
- DEVICE Amber Glasses
- DEVICE Clear Lens Glasses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2019-02-27 |
| Est. Completion | 2022-06-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04378933
The ClinicalTrials.gov registry entry for NCT04378933 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Amber Glasses is the first listed.
NCT04378933 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04378933 about?
NCT04378933 is a clinical study titled "Glasses for Adolescent Delayed Sleep-Wake Phase Disorder". The purpose of this study is to determine if evening amber glasses combined with stable wake times will show an increase in total sleep time (TST) and an advance in sleep onset times (shift earlier) compared to the control group.
What is the current status of trial NCT04378933?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2019-02-27. Estimated completion is 2022-06-03.
What interventions are being tested in trial NCT04378933?
The interventions under investigation include: Amber Glasses (DEVICE), Clear Lens Glasses (DEVICE).
Who is sponsoring clinical trial NCT04378933?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.